Modification of the graft-versus-host syndrome by anti-lymphocyte serum treatment of the donor.
- 1 October 1968
- journal article
- Vol. 3 (8) , 795-800
Abstract
Spleen and lymph node suspensions prepared from parental donor mice pretreated with four daily anti-lymphocyte serum (ALS) injections have been demonstrated to be incapable of inducing a graft-versus-host (GVH) syndrome when injected into F1 hybrid recipient mice. A single ALS injection to the parental donor renders thoracic duct lymphocytes incapable of inducing a GVH response but the activity of spleen cell suspensions is retained.This publication has 13 references indexed in Scilit:
- Modification of the graft-versus-host syndrome by anti-lymphocyte serum treatment of the host.1968
- In vivo and in vitro Effect of Anti-lymphocytic IgG on Sensitized Spleen CellsNature, 1968
- SITE OF ACTION OF ANTILYMPHOCYTE GLOBULINThe Lancet, 1967
- Further experiments on the action of antilymphocytic antiserum.Proceedings of the National Academy of Sciences, 1967
- SUPPRESSION OF COOMBS-POSITIVE HÆMOLYTIC ANAEMIA IN NZB MICE BY ANTILYMPHOCYTE GLOBULINThe Lancet, 1967
- EFFECT OF ANTILYMPHOCYTIC ANTIBODY AND ANTIBODY FRAGMENTS ON SKIN-HOMOGRAFT SURVIVAL AND THE BLOOD-LYMPHOCYTE COUNT IN RATSThe Lancet, 1967
- ACTIVITY OF LYMPHOID TISSUES FROM ANTILYMPHOCYTE-SERUM-TREATED MICEThe Lancet, 1967
- AN IMMUNOSUPPRESSIVE SITE OF ACTION OF HETEROLOGOUS ANTILYMPHOCYTE SERUMThe Lancet, 1967
- STUDIES ON HETEROLOGOUS ANTI-LYMPHOCYTE SERUM IN MICE .I. IN VITRO AND IN VIVO PROPERTIES1966
- The Use of Immunologically Competent Cells in the Treatment of CancerBritish Journal of Cancer, 1962